Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GERON CORPGERN · Entity 4989 | Director | January 13, 2023 | January 18, 2023 |
| NEKTAR THERAPEUTICSNKTR · Entity 4364 | Director | September 16, 2022 | September 21, 2022 |
| Personalis, Inc.PSNL · Entity 4572 | Director | May 12, 2026 | June 11, 2026 |
| VERACYTE, INC.VCYT · Entity 2018 | Director | June 18, 2026 | June 22, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GERON CORP
Report date January 13, 2023 · Filed January 18, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 109,047 |
Reported balance
After 2023-01-13 transaction · row 1
1 source rowRow 1 · 2023-01-13 · Exercise / conversion · Acquired 35,000 · Balance 109,047 |
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.10 · Expires 2023-05-22 | Direct | 0 |
Reported balance
After 2023-01-13 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-01-13 · Exercise / conversion · Disposed 35,000 · Balance 0 F1: The options were fully vested. |
Filing footnotes · ownership attribution and instrument terms
F1: The options were fully vested.
NEKTAR THERAPEUTICS
Report date September 16, 2022 · Filed September 21, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 23,233 |
Reported balance
After 2022-09-16 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-09-16 · Grant · Acquired 10,200 · Balance 23,233 F1: Common stock was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU awarded represents a contingent right to receive, upon vesting of the unit, one share of the Issuer's common stock. F2: This RSU award vests in full, one year following September 16, 2022. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $3.47 · Expires 2030-09-15 | Direct | 20,400 |
Reported balance
After 2022-09-16 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-09-16 · Grant · Acquired 20,400 · Balance 20,400 F3: This stock option vests in equal monthly installments over the one-year period beginning on September 16, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Common stock was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU awarded represents a contingent right to receive, upon vesting of the unit, one share of the Issuer's common stock.
F2: This RSU award vests in full, one year following September 16, 2022.
F3: This stock option vests in equal monthly installments over the one-year period beginning on September 16, 2022.
Personalis, Inc.
Report date May 12, 2026 · Filed June 11, 2026 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 19,756 |
Reported balance
After 2026-05-12 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2026-05-12 · Grant · Acquired 6,250 · Balance 19,756 F1: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 100% of the shares subject to the RSU shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the Company's 2019 Equity Incentive Plan (the "2019 Plan")) through the vesting date. In the event of a Change in Control (as defined in the 2019 Plan), the shares underlying the RSU shall vest immediately prior to the effectiveness of such Change in Control. F2: This amendment corrects the number of shares of Common Stock reported as beneficially owned by the Reporting Person on the Form 4 filed on May 14, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 100% of the shares subject to the RSU shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the Company's 2019 Equity Incentive Plan (the "2019 Plan")) through the vesting date. In the event of a Change in Control (as defined in the 2019 Plan), the shares underlying the RSU shall vest immediately prior to the effectiveness of such Change in Control.
F2: This amendment corrects the number of shares of Common Stock reported as beneficially owned by the Reporting Person on the Form 4 filed on May 14, 2026.
VERACYTE, INC.
Report date June 18, 2026 · Filed June 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 15,097 |
Ending reported balance
After 2026-06-18 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-06-18 · Sale · Disposed 3,200 · Balance 15,626 F1: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 5, 2025. F2: Represents weighted average sales price. Sale prices for the transactions range from $52.26 to $53.26. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Row 2 · 2026-06-18 · Sale · Disposed 529 · Balance 15,097 F1: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 5, 2025. F3: Represents weighted average sales price. Sale prices for the transactions range from $53.29 to $53.70. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. |
Filing footnotes · ownership attribution and instrument terms
F1: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 5, 2025.
F2: Represents weighted average sales price. Sale prices for the transactions range from $52.26 to $53.26. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
F3: Represents weighted average sales price. Sale prices for the transactions range from $53.29 to $53.70. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ILLUMINA, INC.
Report date January 22, 2014 · Filed May 29, 2019
Section 16 reporting ended · disclosed 2019-05-29. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 10,249 |
Reported balance
After 2014-01-22 transaction · row 1
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 1 · 2014-01-22 · Gift · Disposed 200 · Balance 10,249 |
| Common StockSEC Table I · non-derivative | Direct | 10,049 |
Reported balance
After 2019-05-23 transaction · row 2
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 2 · 2019-05-23 · Tax withholding · Disposed 589 · Balance 10,049 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 02, 2019 Filed Jan 4, 2019 22:03 UTC | ILLUMINA, INC. ILMN · Entity 3137 | SaleCommon Stock | 466 | $296.57 | $138,201.34 |
DisclosureSEC source: 0001127602-19-001359 · form4.xml · nonDerivative · entry 11 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,838 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F7 · price: Weighted average sale price representing 466 shares sold ranging from $296.18 to $297.00 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 22:03 UTC | ILLUMINA, INC. ILMN · Entity 3137 | SaleCommon Stock | 365 | $295.72 | $107,937.98 |
DisclosureSEC source: 0001127602-19-001359 · form4.xml · nonDerivative · entry 10 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,304 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F6 · price: Weighted average sale price representing 365 shares sold ranging from $295.17 to $296.10 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 22:03 UTC | ILLUMINA, INC. ILMN · Entity 3137 | SaleCommon Stock | 1,068 | $294.75 | $314,791.08 |
DisclosureSEC source: 0001127602-19-001359 · form4.xml · nonDerivative · entry 9 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,669 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F5 · price: Weighted average sale price representing 1,068 shares sold ranging from $294.17 to $295.08 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 22:03 UTC | ILLUMINA, INC. ILMN · Entity 3137 | SaleCommon Stock | 1,202 | $293.63 | $352,940.74 |
DisclosureSEC source: 0001127602-19-001359 · form4.xml · nonDerivative · entry 8 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,737 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F4 · price: Weighted average sale price representing 1,202 shares sold ranging from $293.02 to $294.01 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 22:03 UTC | ILLUMINA, INC. ILMN · Entity 3137 | SaleCommon Stock | 566 | $292.41 | $165,501.46 |
DisclosureSEC source: 0001127602-19-001359 · form4.xml · nonDerivative · entry 7 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,939 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F3 · price: Weighted average sale price representing 566 shares sold ranging from $292.02 to $293.00 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 22:03 UTC | ILLUMINA, INC. ILMN · Entity 3137 | SaleCommon Stock | 333 | $291.03 | $96,912.72 |
DisclosureSEC source: 0001127602-19-001359 · form4.xml · nonDerivative · entry 6 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,505 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F2 · price: Weighted average sale price representing 333 shares sold ranging from $290.63 to $291.42 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 22:03 UTC | ILLUMINA, INC. ILMN · Entity 3137 | Exercise / conversionCommon Stock | 4,000 | $71.09 | $284,360.00 |
DisclosureSEC source: 0001127602-19-001359 · form4.xml · nonDerivative · entry 5 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,838 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| December 03, 2018 Filed Jan 4, 2019 22:03 UTC | ILLUMINA, INC. ILMN · Entity 3137 | GiftCommon Stock | 44 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-001359 · form4.xml · nonDerivative · entry 4 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,838 Read SEC document |
| November 28, 2018 Filed Jan 4, 2019 22:03 UTC | ILLUMINA, INC. ILMN · Entity 3137 | GiftCommon Stock | 458 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-001359 · form4.xml · nonDerivative · entry 3 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,882 Read SEC document |
| November 27, 2018 Filed Jan 4, 2019 22:03 UTC | ILLUMINA, INC. ILMN · Entity 3137 | GiftCommon Stock | 315 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-001359 · form4.xml · nonDerivative · entry 2 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,340 Read SEC document |
| November 06, 2018 Filed Jan 4, 2019 22:03 UTC | ILLUMINA, INC. ILMN · Entity 3137 | GiftCommon Stock | 184 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-001359 · form4.xml · nonDerivative · entry 1 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,655 Read SEC document |
| September 27, 2018 Filed Oct 2, 2018 00:19 UTC | NEKTAR THERAPEUTICS NKTR · Entity 4364 | GrantStock Option · Derivative | 17,000 | $0.00 Strike: $60.91 | $0.00 |
DisclosureSEC source: 0001209191-18-052906 · doc4.xml · derivative · entry 2 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires 2026-09-26 F3 · derivative.exercise_date: This stock option vests in equal monthly installments over the three-year period beginning on September 30, 2018. Read SEC document |
| September 27, 2018 Filed Oct 2, 2018 00:19 UTC | NEKTAR THERAPEUTICS NKTR · Entity 4364 | GrantCommon Stock | 8,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-052906 · doc4.xml · nonDerivative · entry 1 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,500 F1 · security: This stock award was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the issuer's common stock. F2 · deemedExecutionDate: This restricted stock unit award vests over three years in equal annual installments beginning on September 27, 2018. Read SEC document |
| June 07, 2018 Filed Jun 7, 2018 21:11 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $7.60 | $0.00 |
DisclosureSEC source: 0001384101-18-000040 · wf-form4_152840588040985.xml · derivative · entry 1 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2028-06-07 F1 · derivative.exercise_date: The option becomes exercisable in full on the first anniversary of the date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the option vests in full in the event of a change in control of the Company. Read SEC document |
| May 23, 2018 Filed May 24, 2018 23:17 UTC | ILLUMINA, INC. ILMN · Entity 3137 | GrantCommon Stock | 1,473 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-018872 · form4.xml · nonDerivative · entry 2 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,839 F1 · security: Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date. Read SEC document |
| May 22, 2018 Filed May 24, 2018 23:17 UTC | ILLUMINA, INC. ILMN · Entity 3137 | Tax withholdingCommon Stock | 922 | $270.80 | $249,677.60 |
DisclosureSEC source: 0001127602-18-018872 · form4.xml · nonDerivative · entry 1 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,366 Read SEC document |
| May 21, 2018 Filed May 22, 2018 21:23 UTC | ILLUMINA, INC. ILMN · Entity 3137 | SaleCommon Stock | 400 | $271.21 | $108,485.20 |
DisclosureSEC source: 0001127602-18-018445 · form4.xml · nonDerivative · entry 3 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,288 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F4 · price: Weighted average sale price representing 400 shares sold ranging from $271.10 to $271.31 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| May 21, 2018 Filed May 22, 2018 21:23 UTC | ILLUMINA, INC. ILMN · Entity 3137 | SaleCommon Stock | 400 | $269.29 | $107,716.00 |
DisclosureSEC source: 0001127602-18-018445 · form4.xml · nonDerivative · entry 2 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,688 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F3 · price: Weighted average sale price representing 400 shares sold ranging from $269.03 to $269.56 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| May 21, 2018 Filed May 22, 2018 21:23 UTC | ILLUMINA, INC. ILMN · Entity 3137 | SaleCommon Stock | 200 | $268.01 | $53,601.00 |
DisclosureSEC source: 0001127602-18-018445 · form4.xml · nonDerivative · entry 1 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,088 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F2 · price: Weighted average sale price representing 200 shares sold ranging from $267.55 to $268.46 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| May 15, 2018 Filed May 17, 2018 20:40 UTC | GERON CORP GERN · Entity 4989 | GrantStock Option (right to buy) · Derivative | 70,000 | $0.00 Strike: $3.43 | $0.00 |
DisclosureSEC source: 0000886744-18-000032 · edgar.xml · derivative · entry 1 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2028-05-14 F1 · derivative.exercise_date: This option will vest and become exercisable as to 100% of the shares of common stock subject to such option on the earlier of (i) the date of the next annual meeting of the company's stockholders or (ii) the first anniversary of the date of grant of such option, subject to the non-employee director's continuous service with the company through such dates. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 00:17 UTC | ILLUMINA, INC. ILMN · Entity 3137 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $71.09 | $0.00 |
DisclosureSEC source: 0001127602-18-010420 · form4.xml · derivative · entry 7 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,600 Underlying: Common Stock · 2,000 shares Expires 2023-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 00:17 UTC | ILLUMINA, INC. ILMN · Entity 3137 | SaleCommon Stock | 540 | $230.79 | $124,623.90 |
DisclosureSEC source: 0001127602-18-010420 · form4.xml · nonDerivative · entry 6 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,288 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F6 · price: Weighted average sale price representing 540 shares sold ranging from $230.70 to $230.87 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 00:17 UTC | ILLUMINA, INC. ILMN · Entity 3137 | SaleCommon Stock | 700 | $230.17 | $161,119.00 |
DisclosureSEC source: 0001127602-18-010420 · form4.xml · nonDerivative · entry 5 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,828 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F5 · price: Weighted average sale price representing 700 shares sold ranging from $229.68 to $230.61 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 00:17 UTC | ILLUMINA, INC. ILMN · Entity 3137 | SaleCommon Stock | 200 | $228.60 | $45,720.00 |
DisclosureSEC source: 0001127602-18-010420 · form4.xml · nonDerivative · entry 4 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,528 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F4 · price: Weighted average sale price representing 200 shares sold ranging from $228.50 to $228.70 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 00:17 UTC | ILLUMINA, INC. ILMN · Entity 3137 | SaleCommon Stock | 300 | $227.68 | $68,304.00 |
DisclosureSEC source: 0001127602-18-010420 · form4.xml · nonDerivative · entry 3 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,728 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F3 · price: Weighted average sale price representing 300 shares sold ranging from $227.50 to $227.90 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 00:17 UTC | ILLUMINA, INC. ILMN · Entity 3137 | SaleCommon Stock | 260 | $226.80 | $58,968.52 |
DisclosureSEC source: 0001127602-18-010420 · form4.xml · nonDerivative · entry 2 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,028 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F2 · price: Weighted average sale price representing 260 shares sold ranging from $226.39 to $226.95 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 00:17 UTC | ILLUMINA, INC. ILMN · Entity 3137 | Exercise / conversionCommon Stock | 2,000 | $71.09 | $142,180.00 |
DisclosureSEC source: 0001127602-18-010420 · form4.xml · nonDerivative · entry 1 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,288 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| August 02, 2017 Filed Aug 4, 2017 21:44 UTC | ILLUMINA, INC. ILMN · Entity 3137 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 10,800 | $0.00 Strike: $75.66 | $0.00 |
DisclosureSEC source: 0001127602-17-025058 · form4.xml · derivative · entry 4 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,800 shares Expires 2021-05-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| August 02, 2017 Filed Aug 4, 2017 21:44 UTC | ILLUMINA, INC. ILMN · Entity 3137 | SaleCommon Stock | 10,800 | $195.00 | $2,106,000.00 |
DisclosureSEC source: 0001127602-17-025058 · form4.xml · nonDerivative · entry 2 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,588 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| August 02, 2017 Filed Aug 4, 2017 21:44 UTC | ILLUMINA, INC. ILMN · Entity 3137 | Exercise / conversionCommon Stock | 10,800 | $75.66 | $817,128.00 |
DisclosureSEC source: 0001127602-17-025058 · form4.xml · nonDerivative · entry 1 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,388 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| June 07, 2017 Filed Jun 7, 2017 21:26 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $7.94 | $0.00 |
DisclosureSEC source: 0001384101-17-000044 · wf-form4_149687080291319.xml · derivative · entry 1 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2027-06-07 F1 · derivative.exercise_date: The option becomes exercisable in full on the first anniversary of the date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the option vests in full in the event of a change in control of the Company. Read SEC document |
| May 30, 2017 Filed Jun 2, 2017 01:01 UTC | ILLUMINA, INC. ILMN · Entity 3137 | GrantCommon Stock | 2,305 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-020141 · form4.xml · nonDerivative · entry 1 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,588 F1 · security: Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date. Read SEC document |
| May 18, 2017 Filed May 23, 2017 00:33 UTC | ILLUMINA, INC. ILMN · Entity 3137 | Tax withholdingCommon Stock | 1,141 | $175.89 | $200,690.49 |
DisclosureSEC source: 0001127602-17-019075 · form4.xml · nonDerivative · entry 1 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,283 Read SEC document |
| May 09, 2017 Filed May 11, 2017 00:50 UTC | GERON CORP GERN · Entity 4989 | GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $2.63 | $0.00 |
DisclosureSEC source: 0000886744-17-000027 · edgar.xml · derivative · entry 1 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2027-05-09 F1 · derivative.exercise_date: This option will vest and become exercisable as to 100% of the shares of common stock subject to such option on the earlier of (i) the date of the next annual meeting of the company's stockholders or (ii) the first anniversary of the date of grant of such option, subject to the non-employee director's continuous service with the company through such dates. Read SEC document |
| June 07, 2016 Filed Aug 4, 2017 21:44 UTC | ILLUMINA, INC. ILMN · Entity 3137 | GiftCommon Stock | 300 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-025058 · form4.xml · nonDerivative · entry 3 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,288 Read SEC document |
| January 22, 2014 Filed May 29, 2019 01:01 UTC | ILLUMINA, INC. ILMN · Entity 3137 | GiftCommon Stock | 200 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020073 · form4.xml · nonDerivative · entry 1 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,249 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.